References
Anderson GP (2006) Current issues with beta2-adrenoceptor agonists: pharmacology and molecular and cellular mechanisms. Clin Rev Allergy Immunol 31:119–130
Anderson SD (2006) Beta(2)-Agonists: Introduction. Clin Rev Allergy Immunol 31:103–105
Anderson SD, Caillaud C, Brannan JD (2006) Beta2-agonists and exercise-induced asthma. Clin Rev Allergy Immunol 31:163–180
Bohle B (2006) T-cell epitopes of food allergens. Clin Rev Allergy Immunol 30:97–108
Borchers AT, Chang C, Keen CL, Gershwin ME (2006) Airborne environmental injuries and human health. Clin Rev Allergy Immunol 31:1–101
Borish L, Rosenwasser L, Steinke JW (2006) Fungi in chronic hyperplastic eosinophilic sinusitis: reasonable doubt. Clin Rev Allergy Immunol 30:195–204
Bourrain JL (2006) Occupational contact urticaria. Clin Rev Allergy Immunol 30:39–46
Cockcroft DW (2006) Clinical concerns with inhaled beta2-agonists: adult asthma. Clin Rev Allergy Immunol 31:197–208
Cribier B (2006) Urticaria and hepatitis. Clin Rev Allergy Immunol 30:25–29
Doutre MS (2006) Chronic urticaria and thyroid auto-immunity. Clin Rev Allergy Immunol 30:31–37
Esch RE (2006) Allergens. Clin Rev Allergy Immunol 30:71–72
Fitch KD (2006) beta2-Agonists at the Olympic Games. Clin Rev Allergy Immunol 31:259–268
Grob JJ, Gaudy-Marqueste C (2006) Urticaria and quality of life. Clin Rev Allergy Immunol 30:47–51
Hancox RJ (2006) Concluding remarks: can we explain the association of beta-agonists with asthma mortality? A hypothesis. Clin Rev Allergy Immunol 31:279–288
Hancox RJ (2006) Interactions between corticosteroids and beta2-agonists. Clin Rev Allergy Immunol 31:231–246
Haney S, Hancox RJ (2006) Recovery from bronchoconstriction and bronchodilator tolerance. Clin Rev Allergy Immunol 31:181–196
Hennino A, Berard F, Guillot I, Saad N, Rozieres A, Nicolas JF (2006) Pathophysiology of urticaria. Clin Rev Allergy Immunol 30:3–11
Hoffman DR (2006) Hymenoptera venom allergens. Clin Rev Allergy Immunol 30:109–128
Kauffman HF (2006) Innate immune responses to environmental allergens. Clin Rev Allergy Immunol 30:129–140
Kong JS, Teuber S, Hallett R, Gershwin ME (2006) Mastocytosis: the great masquerader. Clin Rev Allergy Immunol 30:53–60
Kumar A, Teuber SS, Naguwa S, Prindiville T, Gershwin ME (2006) Eosinophilic gastroenteritis and citrus-induced urticaria. Clin Rev Allergy Immunol 30:61–70
Luong A, Marple BF (2006) Sinus surgery: indications and techniques. Clin Rev Allergy Immunol 30:217–222
Mafee MF, Tran BH, Chapa AR (2006) Imaging of rhinosinusitis and its complications: plain film, CT, and MRI. Clin Rev Allergy Immunol 30:165–186
Martinez FD (2006) Serious adverse events and death associated with treatment using long-acting beta-agonists. Clin Rev Allergy Immunol 31:269–278
Mathelier-Fusade P (2006) Drug-induced urticarias. Clin Rev Allergy Immunol 30:19–23
Page CP, Spina D (2006) Beta2-agonists and bronchial hyperresponsiveness. Clin Rev Allergy Immunol 31:143–162
Peachell P (2006) Regulation of mast cells by beta-agonists. Clin Rev Allergy Immunol 31:131–142
Ponikau JU, Sherris DA, Kephart GM, Adolphson C, Kita H (2006) The role of ubiquitous airborne fungi in chronic rhinosinusitis. Clin Rev Allergy Immunol 30:187–194
Salpeter SR, Buckley NS (2006) Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids. Clin Rev Allergy Immunol 31:219–230
Schubert MS (2006) Allergic fungal sinusitis. Clin Rev Allergy Immunol 30:205–216
Slavin RG (2006) Introduction. Clin Rev Allergy Immunol 30:141–142
Smart BA (2006) Is rhinosinusitis a cause of asthma. Clin Rev Allergy Immunol 30:153–164
Staumont-Salle D, Dombrowicz D, Capron M, Delaporte E (2006) Eosinophils and urticaria. Clin Rev Allergy Immunol 30:13–18
Subbarao P, Ratjen F (2006) Beta2-agonists for asthma: the pediatric perspective. Clin Rev Allergy Immunol 31:209–218
Tattersfield AE (2006) Current issues with beta2-adrenoceptor agonists: historical background. Clin Rev Allergy Immunol 31:107–118
Taylor DR (2006) Pharmacogenetics of beta2-agonist drugs in asthma. Clin Rev Allergy Immunol 31:247–258
Verdino P (2006) Structural characterization of pollen allergens. Clin Rev Allergy Immunol 30:73–95
Wald ER (2006) Beginning antibiotics for acute rhinosinusitis and choosing the right treatment. Clin Rev Allergy Immunol 30:143–152
Amigo MC (2007) The Heart and APS. Clin Rev Allergy Immunol 32:178–183
Asherson RA, Cervera R (2007) Pulmonary hypertension, antiphospholipid antibodies, and syndromes. Clin Rev Allergy Immunol 32:153–158
Blank M, Barzilai O, Shoenfeld Y (2007) Molecular mimicry and auto-immunity. Clin Rev Allergy Immunol 32:111–118
Borchers AT, Keen CL, Gershwin ME (2007) Smoking cessation: significance and implications for children. Clin Rev Allergy Immunol, In press
Boren E, Teuber SS, Naguwa SM, Gershwin ME (2007) A critical review of local anesthetic sensitivity. Clin Rev Allergy Immunol 32:119–128
Carp HJ, Shoenfeld Y (2007) Anti-phospholipid antibodies and infertility. Clin Rev Allergy Immunol 32:159–161
Goodarzi H, Trowbridge J, Gallo RL (2007) Innate immunity: a cutaneous perspective. Clin Rev Allergy Immunol, In press
Gorshtein A, Levy Y (2007) Orthopedic involvement in antiphospholipid syndrome. Clin Rev Allergy Immunol 32:167–171
Guillevin L, Pagnoux C, Guilpain P, Bienvenu B, Martinez V, Mouthon L (2007) Indications for biotherapy in systemic vasculitides. Clin Rev Allergy Immunol 32:85–96
Hodak E, David M (2007) Primary anetoderma and antiphospholipid antibodies–review of the literature. Clin Rev Allergy Immunol 32:162–166
Hughes G (2007) Hughes Syndrome: the antiphospholipid syndrome–a clinical overview. Clin Rev Allergy Immunol 32:3–12
Jara LJ, Medina G, Vera-Lastra O (2007) Systemic antiphospholipid syndrome and atherosclerosis. Clin Rev Allergy Immunol 32:172–177
Jonsson MV, Delaleu N, Jonsson R (2007) Animal Models of Sjogren's Syndrome. Clin Rev Allergy Immunol 32:215–224
Katsifis GE, Moutsopoulos NM, Wahl SM (2007) T Lymphocytes in Sjogren's Syndrome: Contributors to and Regulators of Pathophysiology. Clin Rev Allergy Immunol 32:252–264
Kiss E, Shoenfeld Y (2007) Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus. Clin Rev Allergy Immunol 32:37–46
Kong JS, Teuber SS, Gershwin ME (2007) Aspirin and nonsteroidal anti-inflammatory drug hypersensitivity. Clin Rev Allergy Immunol 32:97–110
Liberato B, Levy RA (2007) Antiphospholipid syndrome and cognition. Clin Rev Allergy Immunol 32:188–191
Maeurer M (2007) High-content T-cell and B-cell analysis. Clin Rev Allergy Immunol 32:75–84
Manoussakis MN, Kapsogeorgou EK (2007) The Role of epithelial cells in the pathogenesis of Sjogren's syndrome. Clin Rev Allergy Immunol 32:225–230
Matthias T, Shoenfeld Y (2007) Cutting edge issues in allergy and clinical immunology. Clin Rev Allergy Immunol 32:1–2
Mavragani CP, Moutsopoulos HM (2007) Conventional therapy of Sjogren's syndrome. Clin Rev Allergy Immunol 32:284–291
Meijer JM, Pijpe J, Bootsma H, Vissink A, Kallenberg CG (2007) The future of biologic agents in the treatment of Sjogren's syndrome. Clin Rev Allergy Immunol 32:292–297
Meroni PL, Ronda N, De Angelis V, Grossi C, Raschi E, Borghi MO (2007) Role of anti-beta2 glycoprotein I antibodies in antiphospholipid syndrome: in vitro and in vivo studies. Clin Rev Allergy Immunol 32:67–74
Moutsopoulos HM (2007) Sjogren's syndrome or autoimmune epithelitis. Clin Rev Allergy Immunol 32:199–200
Nichols D, Chmiel J, Berger M (2007) Chronic inflammation in the cystic fibrosis lung: Alterations in inter- and intracellular signaling. Clin Rev Allergy Immunol, In press
Ramesh S (2007) Food allergy overview in children. Clin Rev Allergy Immunol, In press
Ramos-Casals M, Brito-Zeron P, Font J (2007) Lessons from diseases mimicking Sjogren's syndrome. Clin Rev Allergy Immunol 32:275–283
Reinstein E, Shoenfeld Y (2007) Antiphospholipid syndrome and cancer. Clin Rev Allergy Immunol 32:184–187
Routsias JG, Tzioufas AG (2007) Sjogren's syndrome-study of autoantigens and autoantibodies. Clin Rev Allergy Immunol 32:238–251
Shoenfeld Y (2007) APS–more systemic disease than SLE. Clin Rev Allergy Immunol 32:129–130
Shovman O, Gilburd B, Barzilai O, Langevitz P, Shoenfeld Y (2007) Novel insights into associations of antibodies against cardiolipin and beta2-glycoprotein I with clinical features of antiphospholipid syndrome. Clin Rev Allergy Immunol 32:145–152
Steiner G (2007) Auto-antibodies and autoreactive T-cells in rheumatoid arthritis: pathogenetic players and diagnostic tools. Clin Rev Allergy Immunol 32:23–36
Tarr T, Lakos G, Bhattoa HP, Soltesz P, Shoenfeld Y, Szegedi G et al (2007) Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up. Clin Rev Allergy Immunol 32:131–137
Toubi E, Shoenfeld Y (2007) Livedo reticularis as a criterion for antiphospholipid syndrome. Clin Rev Allergy Immunol 32:138–144
Triantafyllopoulou A, Moutsopoulos H (2007) Persistent viral infection in primary Sjogren's syndrome: review and perspectives. Clin Rev Allergy Immunol 32:210–214
Voulgarelis M, Skopouli FN (2007) Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients. Clin Rev Allergy Immunol 32:265–274
Warger T, Rechtsteiner G, Schmid B, Osterloh P, Schild H, Radsak MP (2007) Transcutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protection. Clin Rev Allergy Immunol 32:57–66
Welliver RC, Sr (2007) The immune response to respiratory syncytial virus infection: rriend or Foe? Clin Rev Allergy Immunol, In press
Wiik AS (2007) The immune response to citrullinated proteins in patients with rheumatoid arthritis: genetic, clinical, technical, and epidemiological aspects. Clin Rev Allergy Immunol 32:13–22
Williams PH, Cobb BL, Namjou B, Scofield RH, Sawalha AH, Harley JB (2007) Horizons in Sjogren's syndrome genetics. Clin Rev Allergy Immunol 32:201–209
Wu R, Shovman O, Zhang Y, Gilburd B, Zandman-Goddard G, Shoenfeld Y (2007) Increased prevalence of anti-third generation cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and CREST syndrome. Clin Rev Allergy Immunol 32:47–56
Yehudai D, Shoenfeld Y, Toubi E (2007) Looking into the eyes of patients with antiphospholipid syndrome. Clin Rev Allergy Immunol 32:192–197
Youinou P, Devauchelle V, Hutin P, Le Berre R, Saraux A, Pers JO (2007) A conspicuous role for B cells in Sjogren's syndrome. Clin Rev Allergy Immunol 32:231–237
Abou-Raya A, Abou-Raya S (2006) Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. Autoimmun Rev 5:331–337
Aoki CA, Roifman CM, Lian ZX, Bowlus CL, Norman GL, Shoenfeld Y et al (2006) IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun 27:50–53
Asherson RA (2006) The catastrophic antiphospholipid (Asherson's) syndrome. Autoimmun Rev 6:64–67
Borchers AT, Selmi C, Cheema G, Keen CL, Shoenfeld Y, Gershwin ME (2006) Juvenile idiopathic arthritis. Autoimmun Rev 5:279–298
Brandt D, Gershwin ME (2006) Common variable immune deficiency and autoimmunity. Autoimmun Rev 5:465–470
Chuang YH, Lian ZX, Tsuneyama K, Chiang BL, Ansari AA, Coppel RL et al (2006) Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis. J Autoimmun 26:232–240
Damoiseaux JG, Tervaert JW (2006) From ANA to ENA: how to proceed. Autoimmun Rev 5:10–17
Denkberg G, Reiter Y (2006) Recombinant antibodies with T-cell receptor-like specificity: novel tools to study MHC class I presentation. Autoimmun Rev 5:252–257
Eisenlohr LC, Rothstein JL (2006) Oncogenic inflammation and autoimmune disease. Autoimmun Rev 6:107–114
Kong JS, Teuber SS, Gershwin ME (2006) Potential adverse events with biologic response modifiers. Autoimmun Rev 5:471–485
Okada T, Inaba M, Naiki M, Lian ZX, Gershwin ME, Ikehara S (2007) Comparative immunobiology of thymic DC mRNA in autoimmune-prone mice. J Autoimmun 28:41–45
Rieger R, Leung PS, Jeddeloh MR, Kurth MJ, Nantz MH, Lam KS et al (2006) Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun 27:7–16
Abbas AK, Lohr J, Knoechel B, Nagabhushanam V (2004) T cell tolerance and autoimmunity. Autoimmun Rev 3:471–475
Avrameas S, Ternynck T, Tsonis IA, Lymberi P (2007) Naturally occurring B-cell autoreactivity: A critical overview. J Autoimmun 29:213–218
Cohen IR (2007) Biomarkers, self-antigens and the immunological homunculus. J Autoimmun 29:246–249
Foreman AL, Van de Water J, Gougeon ML, Gershwin ME (2007) B cells in autoimmune diseases: insights from analyses of immunoglobulin variable (Ig V) gene usage. Autoimmun Rev 6:387–401
Gebe JA, Unrath KA, Yue BB, Miyake T, Falk BA, Nepom GT (2007) Autoreactive human T-cell receptor initiates insulitis and impaired glucose tolerance in HLA DR4 transgenic mice. J Autoimmun, In press
Gleicher N, Barad D, Weghofer A (2007) Functional autoantibodies, a new paradigm in autoimmunity. Autoimmun Rev 7:42–45
Lan RY, Mackay IR, Eric Gershwin M (2007) Regulatory T cells in the prevention of mucosal inflammatory diseases: Patrolling the border. J Autoimmun 29:272–280
Lang KS, Burow A, Kurrer M, Lang PA, Recher M (2007) The role of the innate immune response in autoimmune disease. J Autoimmun 29:206–212
Lleo A, Invernizzi P, Selmi C, Coppel RL, Alpini G, Podda M et al (2007) Autophagy: highlighting a novel player in the autoimmunity scenario. J Autoimmun 29:61–68
Lutz HU (2007) Homeostatic roles of naturally occurring antibodies: An overview. J Autoimmun 29:287–294
Mantovani A, Garlanda C, Locati M, Rodriguez TV, Feo SG, Savino B et al (2007) Regulatory pathways in inflammation. Autoimmun Rev 7:8–11
Milner J, Ward J, Keane-Myers A, Min B, Paul WE (2007) Repertoire-dependent immunopathology. J Autoimmun 29:257–261
Papadimitraki ED, Bertsias GK, Boumpas DT (2007) Toll like receptors and autoimmunity: A critical appraisal. J Autoimmun 29:310–318
Pasquali JL, Soulas-Sprauel P, Korganow AS, Martin T (2007) Auto-reactive B cells in transgenic mice. J Autoimmun 29:250–256
Peng Y, Martin DA, Kenkel J, Zhang K, Ogden CA, Elkon KB (2007) Innate and adaptive immune response to apoptotic cells. J Autoimmun 29:303–309
Rowley B, Tang L, Shinton S, Hayakawa K, Hardy RR (2007) Autoreactive B-1 B cells: Constraints on natural autoantibody B cell antigen receptors. J Autoimmun 29:236–245
Ryan KR, Patel SD, Stephens LA, Anderton SM (2007) Death, adaptation and regulation: The three pillars of immune tolerance restrict the risk of autoimmune disease caused by molecular mimicry. J Autoimmun 29:262–271
Selmi C (2007) One year in autoimmunity. Autoimmun Rev 7:85–93
Shimada A, Kanazawa Y, Motohashi Y, Yamada S, Maruyama T, Ikegami H, et al (2007) Evidence for association between vitamin D receptor BsmI polymorphism and type 1 diabetes in Japanese. J Autoimmun, In press
Tsonis IA, Avrameas S, Moutsopoulos HM (2007) Autoimmunity and pathophysiology. J Autoimmun 29:203–205
Zelenay S, Moraes Fontes MF, Fesel C, Demengeot J, Coutinho A (2007) Physiopathology of natural auto-antibodies: the case for regulation. J Autoimmun 29:229–235
Allina J, Hu B, Sullivan DM, Fiel MI, Thung SN, Bronk SF et al (2006) T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun 27:232–241
Rieger R, Gershwin ME (2007) The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun 28:76–84
Pordeus V, Szyper-Kravitz M, Levy R, Vaz N, Shoenfeld Y (2007) Infections and autoimmunity: a panorama. Clin Rev Allergy Immunol, In press
Rose N (2007) The adjuvant effect in infection and autoimmunity. Clin Rev Allergy Immunol, In press
Meroni P, Gerosa M, Raschi E, Scurati S, Grossi C, Borghi M (2007) Updating on the pathogenic mechanisms of the antiphospholipid antibodies-associated pregnancy loss. Clin Rev Allergy Immunol, In press
Toubi E (2007) The role of CD4 + CD25 + T regulatory cells in autoimmune diseases. Clin Rev Allergy Immunol, In press
Veldman C, Feliciani C (2007) Pemphigus: A complex T-cell dependent autoimmune disorder leading to acantholysis. Clin Rev Allergy Immunol, In press
Appenzeller S, Pike G, Clarke A (2007) Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus. Clin Rev Allergy Immunol, In press
Blank M, Shoenfeld Y (2007) Histidine-rich glycoprotein modulation of immune/autoimmune, vascular and coagulation systems. Clin Rev Allergy Immunol, In press
Coca A, Anolik J (2007) Targeted biologic approaches to the treatment of systemic vasculitis. Clin Rev Allergy Immunol, In press
Csernok E, Moosig F, Gross W (2007) Pathways to ANCA production: from maturation of dendritic cells by proteinase 3 to B lymphocytes maturation in Wegener's granuloma. Clin Rev Allergy Immunol, In press
Renaudineau Y, Dalekos G, Gueguen P, Zachou K, Youinou P (2007) Anti-alpha-actinin antibodies cross-react with anti-ssDNA antibodies in active autoimmune hepatitis. Clin Rev Allergy Immunol, In press
Rhiannon J (2007) Systemic lupus erythematosus involving the nervous system: Presentation, pathogenesis and management. Clin Rev Allergy Immunol, In press
Witte T (2007) IgM antibodies against dsDNA in SLE. Clin Rev Allergy Immunol, In press
Martin P, Malizia A, Rewald E (2007) A propos time and autoimmunity. Clin Rev Allergy Immunol, In press
Ozcelik T (2007) X-chromosome inactivation and female predisposition to autoimmunity. Clin Rev Allergy Immunol, In press
Uz E, Loubiere L, Gadi V, Ozbalkan Z, Stewart J, Nelson J, et al (2007) Skewed X-chromosome inactivation in scleroderma. Clin Rev Allergy Immunol, In press
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sherer, Y., Matthias, T. & Shoenfeld, Y. Cutting Edge Issues in Autoimmunity. Clinic Rev Allerg Immunol 34, 275–278 (2008). https://doi.org/10.1007/s12016-007-8047-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-007-8047-9